Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

Impact of paediatric onset primary sclerosing cholangitis on clinical course and outcome of inflammatory bowel disease: a case-control population-based study in Finland.

Tenca A, Jaakkola T, Färkkilä M, Arola J, Kolho KL.

Scand J Gastroenterol. 2019 Aug 10:1-7. doi: 10.1080/00365521.2019.1648547. [Epub ahead of print]

PMID:
31402720
2.

Risks of light and moderate alcohol use in fatty liver disease - follow-up of population cohorts.

Åberg F, Puukka P, Salomaa V, Männistö S, Lundqvist A, Valsta L, Perola M, Färkkilä M, Jula A.

Hepatology. 2019 Jul 19. doi: 10.1002/hep.30864. [Epub ahead of print]

PMID:
31323122
3.

Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study.

Puolanne AM, Kolho KL, Alfthan H, Färkkilä M.

Scand J Gastroenterol. 2019 Jul 2:1-6. doi: 10.1080/00365521.2019.1618910. [Epub ahead of print]

PMID:
31264494
4.

Genetic and lifestyle risk factors for advanced liver disease among men and women.

Sahlman P, Nissinen M, Puukka P, Jula A, Salomaa V, Männistö S, Lundqvist A, Valsta L, Perola M, Färkkilä M, Åberg F.

J Gastroenterol Hepatol. 2019 Jul 1. doi: 10.1111/jgh.14770. [Epub ahead of print]

PMID:
31260143
5.

Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease.

Åberg F, Puukka P, Salomaa V, Männistö S, Lundqvist A, Valsta L, Perola M, Jula A, Färkkilä M.

Clin Gastroenterol Hepatol. 2019 Jun 27. pii: S1542-3565(19)30727-X. doi: 10.1016/j.cgh.2019.06.036. [Epub ahead of print]

PMID:
31255807
6.

Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes J, Schreiber S, Bokemeyer B, Bethge J; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, Cho JH, McGovern DPB, Daly MJ.

PLoS Genet. 2019 May 30;15(5):e1008190. doi: 10.1371/journal.pgen.1008190. eCollection 2019 May.

7.

Impact of anti-TNF-alpha therapy on colectomy rate and indications for colectomy in ulcerative colitis: comparison of two patient cohorts from 2005 to 2007 and from 2014 to 2016.

Kolehmainen S, Lepistö A, Färkkilä M.

Scand J Gastroenterol. 2019 Jun;54(6):707-711. doi: 10.1080/00365521.2019.1620326. Epub 2019 May 28.

PMID:
31136207
8.

Association between Ménière's disease and vestibular migraine.

Pyykkö I, Manchaiah V, Färkkilä M, Kentala E, Zou J.

Auris Nasus Larynx. 2019 Oct;46(5):724-733. doi: 10.1016/j.anl.2019.02.002. Epub 2019 May 1.

PMID:
31054848
9.

Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland.

Puustinen L, Barner-Rasmussen N, Pukkala E, Färkkilä M.

Dig Liver Dis. 2019 Sep;51(9):1294-1299. doi: 10.1016/j.dld.2019.01.015. Epub 2019 Feb 10.

PMID:
30850346
10.

A High Prevalence of Gastrointestinal Manifestations in Common Variable Immunodeficiency.

Pikkarainen S, Martelius T, Ristimäki A, Siitonen S, Seppänen MRJ, Färkkilä M.

Am J Gastroenterol. 2019 Apr;114(4):648-655. doi: 10.14309/ajg.0000000000000140.

11.

Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.

Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J.

JAMA Oncol. 2018 Nov 1;4(11):1576-1582. doi: 10.1001/jamaoncol.2018.3054. Retraction in: JAMA Oncol. 2019 May 1;5(5):744-745.

12.

Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families.

Gormley P, Kurki MI, Hiekkala ME, Veerapen K, Häppölä P, Mitchell AA, Lal D, Palta P, Surakka I, Kaunisto MA, Hämäläinen E, Vepsäläinen S, Havanka H, Harno H, Ilmavirta M, Nissilä M, Säkö E, Sumelahti ML, Liukkonen J, Sillanpää M, Metsähonkala L, Koskinen S, Lehtimäki T, Raitakari O, Männikkö M, Ran C, Belin AC, Jousilahti P, Anttila V, Salomaa V, Artto V, Färkkilä M; 23andMe Research Team; International Headache Genetics Consortium (IHGC), Runz H, Daly MJ, Neale BM, Ripatti S, Kallela M, Wessman M, Palotie A.

Neuron. 2018 Sep 5;99(5):1098. doi: 10.1016/j.neuron.2018.08.029. No abstract available.

13.

Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.

Vitikainen K, Haapamäki J, Färkkilä M, Anttila VJ, Arkkila P.

Scand J Gastroenterol. 2018 Aug;53(8):947-951. doi: 10.1080/00365521.2018.1492012. Epub 2018 Jul 25.

PMID:
30041549
14.

The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.

Tenca A, Mustonen H, Lind K, Lantto E, Kolho KL, Boyd S, Arola J, Jokelainen K, Färkkilä M.

Liver Int. 2018 Dec;38(12):2329-2339. doi: 10.1111/liv.13899. Epub 2018 Jul 18.

PMID:
29901259
15.

No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis.

Ponsioen CY, Arnelo U, Bergquist A, Rauws EA, Paulsen V, Cantú P, Parzanese I, De Vries EM, van Munster KN, Said K, Chazouillères O, Desaint B, Kemgang A, Färkkilä M, Van der Merwe S, Van Steenbergen W, Marschall HU, Stotzer PO, Thorburn D, Pereira SP, Aabakken L.

Gastroenterology. 2018 Sep;155(3):752-759.e5. doi: 10.1053/j.gastro.2018.05.034. Epub 2018 May 24.

PMID:
29803836
16.

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes J, Schreiber S, Bokemeyer B, Bethge J; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, Cho JH, McGovern DPB, Daly MJ.

PLoS Genet. 2018 May 24;14(5):e1007329. doi: 10.1371/journal.pgen.1007329. eCollection 2018 May. Erratum in: PLoS Genet. 2019 May 30;15(5):e1008190.

17.

Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families.

Gormley P, Kurki MI, Hiekkala ME, Veerapen K, Häppölä P, Mitchell AA, Lal D, Palta P, Surakka I, Kaunisto MA, Hämäläinen E, Vepsäläinen S, Havanka H, Harno H, Ilmavirta M, Nissilä M, Säkö E, Sumelahti ML, Liukkonen J, Sillanpää M, Metsähonkala L, Koskinen S, Lehtimäki T, Raitakari O, Männikkö M, Ran C, Belin AC, Jousilahti P, Anttila V, Salomaa V, Artto V, Färkkilä M; 23andMe Research Team; International Headache Genetics Consortium (IHGC), Runz H, Daly MJ, Neale BM, Ripatti S, Kallela M, Wessman M, Palotie A.

Neuron. 2018 May 16;98(4):743-753.e4. doi: 10.1016/j.neuron.2018.04.014. Epub 2018 May 3. Erratum in: Neuron. 2018 Sep 5;99(5):1098.

18.

Noncholesterol Sterols as Surrogate Markers in Patients with Severe Alcoholic Hepatitis.

Sahlman P, Nissinen M, Simonen P, Färkkilä M.

Lipids. 2018 Mar;53(3):323-334. doi: 10.1002/lipd.12033. Epub 2018 Apr 16.

PMID:
29663389
19.

The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families.

Hiekkala ME, Vuola P, Artto V, Häppölä P, Häppölä E, Vepsäläinen S, Cuenca-León E, Lal D, Gormley P, Hämäläinen E, Ilmavirta M, Nissilä M, Säkö E, Sumelahti ML, Harno H, Havanka H, Keski-Säntti P, Färkkilä M, Palotie A, Wessman M, Kaunisto MA, Kallela M.

Cephalalgia. 2018 Oct;38(12):1849-1863. doi: 10.1177/0333102418761041. Epub 2018 Feb 27.

PMID:
29486580
20.

Inflammatory bowel disease and anemia: intravenous iron treatment.

Kangaspunta M, Haapamäki J, Färkkilä M, Arkkila P.

Scand J Gastroenterol. 2018 Apr;53(4):430-434. doi: 10.1080/00365521.2018.1441435. Epub 2018 Feb 22.

PMID:
29468908
21.

Fecal Calprotectin Test Performed at Home: A Prospective Study of Pediatric Patients With Inflammatory Bowel Disease.

Piekkala M, Alfthan H, Merras-Salmio L, Puustinen Wikström A, Heiskanen K, Jaakkola T, Klemetti P, Färkkilä M, Kolho KL.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):926-931. doi: 10.1097/MPG.0000000000001861.

PMID:
29240011
22.

Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population.

Åberg F, Helenius-Hietala J, Puukka P, Färkkilä M, Jula A.

Hepatology. 2018 Jun;67(6):2141-2149. doi: 10.1002/hep.29631. Epub 2018 Apr 16.

PMID:
29164643
23.

Unexpectedly High Prevalence of Common Variable Immunodeficiency in Finland.

Selenius JS, Martelius T, Pikkarainen S, Siitonen S, Mattila E, Pietikäinen R, Suomalainen P, Aalto AH, Saarela J, Einarsdottir E, Järvinen A, Färkkilä M, Kere J, Seppänen M.

Front Immunol. 2017 Sep 28;8:1190. doi: 10.3389/fimmu.2017.01190. eCollection 2017.

24.

Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.

Boyd S, Vannas M, Jokelainen K, Isoniemi H, Mäkisalo H, Färkkilä MA, Arola J.

World J Gastroenterol. 2017 Sep 7;23(33):6147-6154. doi: 10.3748/wjg.v23.i33.6147.

25.

Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.

Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.

Dig Dis Sci. 2017 Nov;62(11):3123-3130. doi: 10.1007/s10620-017-4770-0. Epub 2017 Sep 25.

PMID:
28948412
26.

Outcomes of patients hospitalized with peptic ulcer disease diagnosed in acute upper endoscopy.

Malmi H, Kautiainen H, Virta LJ, Färkkilä MA.

Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1251-1257. doi: 10.1097/MEG.0000000000000951.

PMID:
28857894
27.

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.

Pereira P, Aho V, Arola J, Boyd S, Jokelainen K, Paulin L, Auvinen P, Färkkilä M.

PLoS One. 2017 Aug 10;12(8):e0182924. doi: 10.1371/journal.pone.0182924. eCollection 2017.

28.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Färkkilä M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Müller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K; International PSC Study Group, The UK PSC Consortium, Chapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK.

Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4.

29.

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.

Dalgard O, Weiland O, Noraberg G, Karlsen L, Heggelund L, Färkkilâ M, Balslev U, Belard E, Øvrehus A, Skalshøi Kjær M, Krarup H, Thorup Røge B, Hallager S, Madsen LG, Lund Laursen A, Lagging M, Weis N.

PLoS One. 2017 Jul 13;12(7):e0179764. doi: 10.1371/journal.pone.0179764. eCollection 2017.

30.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657
31.

Cohort profile: the Nordic Antireflux Surgery Cohort (NordASCo).

Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, Euler-Chelpin MV, Lagergren J.

BMJ Open. 2017 Jun 8;7(6):e016505. doi: 10.1136/bmjopen-2017-016505.

32.

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.

Fickert P, Hirschfield GM, Denk G, Marschall HU, Altorjay I, Färkkilä M, Schramm C, Spengler U, Chapman R, Bergquist A, Schrumpf E, Nevens F, Trivedi P, Reiter FP, Tornai I, Halilbasic E, Greinwald R, Pröls M, Manns MP, Trauner M; European PSC norUDCA Study Group.

J Hepatol. 2017 Sep;67(3):549-558. doi: 10.1016/j.jhep.2017.05.009. Epub 2017 May 18.

33.

Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis.

Vannas MJ, Boyd S, Färkkilä MA, Arola J, Isoniemi H.

Liver Int. 2017 May;37(5):735-742. doi: 10.1111/liv.13276. Epub 2016 Nov 7.

PMID:
28453918
34.

Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.

Aabakken L, Karlsen TH, Albert J, Arvanitakis M, Chazouilleres O, Dumonceau JM, Färkkilä M, Fickert P, Hirschfield GM, Laghi A, Marzioni M, Fernandez M, Pereira SP, Pohl J, Poley JW, Ponsioen CY, Schramm C, Swahn F, Tringali A, Hassan C.

Endoscopy. 2017 Jun;49(6):588-608. doi: 10.1055/s-0043-107029. Epub 2017 Apr 18.

35.

31Phosphorus magnetic resonance spectroscopy of the liver for evaluating inflammation and fibrosis in autoimmune hepatitis.

Puustinen L, Hakkarainen A, Kivisaari R, Boyd S, Nieminen U, Färkkilä M, Lundbom N, Arkkila P.

Scand J Gastroenterol. 2017 Aug;52(8):886-892. doi: 10.1080/00365521.2017.1315738. Epub 2017 Apr 17.

PMID:
28415898
36.

Biliary Anomalies in Patients With HNF1B Diabetes.

Kettunen JLT, Parviainen H, Miettinen PJ, Färkkilä M, Tamminen M, Salonen P, Lantto E, Tuomi T.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):2075-2082. doi: 10.1210/jc.2017-00061.

PMID:
28324003
37.

Magnetic Resonance Imaging of Internal Jugular Veins in Multiple Sclerosis: Interobserver Agreement and Comparison with Doppler Ultrasound Examination.

Laukontaus SJ, Pekkola J, Numminen J, Kagayama T, Lepäntalo M, Färkkilä M, Atula S, Tienari P, Venermo M.

Ann Vasc Surg. 2017 Jul;42:84-92. doi: 10.1016/j.avsg.2016.10.060. Epub 2017 Mar 11.

PMID:
28300678
38.

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group.

Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6.

39.

Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.

de Vries EMG, Färkkilä M, Milkiewicz P, Hov JR, Eksteen B, Thorburn D, Chazouillères O, Pares A, Nygård S, Gilja OH, Wunsch E, Invernizzi P, Carbone M, Bernuzzi F, Boberg KM, Røsjø H, Rosenberg W, Beuers UH, Ponsioen CY, Karlsen TH, Vesterhus M.

Liver Int. 2017 Oct;37(10):1554-1561. doi: 10.1111/liv.13402. Epub 2017 Apr 13.

40.

Histologic surveillance after liver transplantation due to autoimmune hepatitis.

Puustinen L, Boyd S, Arkkila P, Isoniemi H, Arola J, Färkkilä M.

Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12936. Epub 2017 Apr 12.

PMID:
28235132
41.

Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.

Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F.

J Hepatol. 2017 Jun;66(6):1214-1222. doi: 10.1016/j.jhep.2017.01.019. Epub 2017 Feb 2.

PMID:
28161472
42.

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Bommelaer G, Coffin B, Roblin X, van Assche G, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, de Vos M, Lambert J, Mary JY, Louis E; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Gut. 2018 Feb;67(2):237-243. doi: 10.1136/gutjnl-2016-313060. Epub 2017 Jan 4.

43.

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.

Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Müller T, Schramm C, Sterneck M, Weismüller TJ, Gotthardt DN, Ellinghaus D, Braun F, Teufel A, Laudes M, Lieb W, Jacobs G, Beuers U, Weersma RK, Wijmenga C, Marschall HU, Milkiewicz P, Pares A, Kontula K, Chazouillères O, Invernizzi P, Goode E, Spiess K, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Floreani A, Gulamhusein AF, Eaton JE, Schreiber S, Coltescu C, Bowlus CL, Luketic VA, Odin JA, Chopra KB, Kowdley KV, Chalasani N, Manns MP, Srivastava B, Mells G, Sandford RN, Alexander G, Gaffney DJ, Chapman RW, Hirschfield GM, de Andrade M; UK-PSC Consortium; International IBD Genetics Consortium; International PSC Study Group, Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN, Anderson CA.

Nat Genet. 2017 Feb;49(2):269-273. doi: 10.1038/ng.3745. Epub 2016 Dec 19.

44.

Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.

de Vries EM, de Krijger M, Färkkilä M, Arola J, Schirmacher P, Gotthardt D, Goeppert B, Trivedi PJ, Hirschfield GM, Ytting H, Vainer B, Buuren HR, Biermann K, Harms MH, Chazouilleres O, Wendum D, Kemgang AD, Chapman RW, Wang LM, Williamson KD, Gouw AS, Paradis V, Sempoux C, Beuers U, Hübscher SG, Verheij J, Ponsioen CY.

Hepatology. 2017 Mar;65(3):907-919. doi: 10.1002/hep.28963. Epub 2017 Jan 11.

PMID:
27880989
45.

Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis.

Puustinen L, Boyd S, Mustonen H, Arkkila P, Arola J, Färkkilä M.

Scand J Gastroenterol. 2017 Mar;52(3):321-327. doi: 10.1080/00365521.2016.1253768. Epub 2016 Nov 16.

PMID:
27846740
46.

Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.

Molander P, Färkkilä M, Kemppainen H, Blomster T, Jussila A, Mustonen H, Sipponen T.

Scand J Gastroenterol. 2017 Mar;52(3):284-290. doi: 10.1080/00365521.2016.1250942. Epub 2016 Nov 3.

PMID:
27806638
47.

Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.

Boyd S, Mustonen H, Tenca A, Jokelainen K, Arola J, Färkkilä MA.

Scand J Gastroenterol. 2017 Feb;52(2):242-249. doi: 10.1080/00365521.2016.1250281. Epub 2016 Nov 3.

PMID:
27806633
48.

Human leucocyte antigens B*08, DRB1*03 and DRB1*13 are significantly associated with autoimmune liver and biliary diseases in Finnish children.

Ylinen E, Salmela L, Peräsaari J, Jaatinen T, Tenca A, Vapalahti O, Färkkilä M, Jalanko H, Kolho KL.

Acta Paediatr. 2017 Feb;106(2):322-326. doi: 10.1111/apa.13641. Epub 2016 Nov 16.

PMID:
27759901
49.

Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up.

Lehtola E, Haapamäki J, Färkkilä MA.

Scand J Gastroenterol. 2016 Dec;51(12):1476-1481. Epub 2016 Aug 16.

PMID:
27686143
50.

Corrigendum: Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine.

Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, Farh KH, Cuenca-Leon E, Muona M, Furlotte NA, Kurth T, Ingason A, McMahon G, Ligthart L, Terwindt GM, Kallela M, Freilinger TM, Ran C, Gordon SG, Stam AH, Steinberg S, Borck G, Koiranen M, Quaye L, Adams HH, Lehtimäki T, Sarin AP, Wedenoja J, Hinds DA, Buring JE, Schürks M, Ridker PM, Hrafnsdottir MG, Stefansson H, Ring SM, Hottenga JJ, Penninx BW, Färkkilä M, Artto V, Kaunisto M, Vepsäläinen S, Malik R, Heath AC, Madden PA, Martin NG, Montgomery GW, Kurki MI, Kals M, Mägi R, Pärn K, Hämäläinen E, Huang H, Byrnes AE, Franke L, Huang J, Stergiakouli E, Lee PH, Sandor C, Webber C, Cader Z, Muller-Myhsok B, Schreiber S, Meitinger T, Eriksson JG, Salomaa V, Heikkilä K, Loehrer E, Uitterlinden AG, Hofman A, van Duijn CM, Cherkas L, Pedersen LM, Stubhaug A, Nielsen CS, Männikkö M, Mihailov E, Milani L, Göbel H, Esserlind AL, Christensen AF, Hansen TF, Werge T; International Headache Genetics Consortium, Kaprio J, Aromaa AJ, Raitakari O, Ikram MA, Spector T, Järvelin MR, Metspalu A, Kubisch C, Strachan DP, Ferrari MD, Belin AC, Dichgans M, Wessman M, van den Maagdenberg AM, Zwart JA, Boomsma DI, Smith GD, Stefansson K, Eriksson N, Daly MJ, Neale BM, Olesen J, Chasman DI, Nyholt DR, Palotie A.

Nat Genet. 2016 Sep 28;48(10):1296. doi: 10.1038/ng1016-1296c. No abstract available.

PMID:
27681292

Supplemental Content

Loading ...
Support Center